- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
Medical Resources sees Q2 numbers boom
The acquisition drive under way at imaging services provider Medical Resources is paying off with sharply higher financial numbers for the Hackensack, NJ, company. Medical Resources last week reported second-quarter (end-June) revenues of $51.8 million,
The acquisition drive under way at imaging services provider Medical Resources is paying off with sharply higher financial numbers for the Hackensack, NJ, company. Medical Resources last week reported second-quarter (end-June) revenues of $51.8 million, up 177% compared with $18.7 million in the same period last year. The company's net income grew as well, climbing to $4.2 million compared with $1.6 million in the second quarter of 1996. In addition to the positive impact of recent acquisitions, Medical Resources saw a 10% increase in same-center revenues, while revenues in its temporary staffing business doubled.
In other news, Medical Resources has made two more acquisitions in recent weeks that boost its position in Florida. The company bought an imaging center in Miami for $1.7 million in stock, and acquired an imaging facility in Jupiter for $2.1 million in cash and stock. The Miami center has annual revenues of $1.1 million, while the Jupiter center's annual revenues are $1.3 million. Medical Resources now owns 85 imaging centers.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.
